Press Releases
To stay up to date with our development, sign up for a subscription.
2021
2021-12-22 11:00
“With the application in Italy, we are hoping to bring our Sedaconda products to yet another important European market. Having received market approval in 14 European countries to date, we are aiming to receive further approvals in Poland, Italy...
2021-12-03 01:15
Sedana Medical AB (publ) (SEDANA: FN Stockholm) (“Sedana Medical” or the “Company”) has, by exercise of the authorisation from the annual general meeting held 10 May 2021, successfully carried out a directed issue of 7,150,000...
2021-12-02 17:50
Sedana Medical AB (publ) (SEDANA: FN Stockholm) (“Sedana Medical” or “Company”) hereby announces the Company's intention to, by exercise of the authorisation from the annual general meeting held 10 May 2021, carry out a directed...
2021-11-24 08:30
Sedana Medical is aiming for a combination registration of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane) for inhaled sedation of mechanically ventilated patients in intensive care. Provided that the IND is approved, the...
2021-11-04 07:00
Third quarter 2021 January-September 2021 CEO Comments Approval in 11 EU markets and continued sales growth provide strong platform for the upcoming launch This third quarter report is my first as Sedana Medical’s CEO. In the first weeks after joining...
2021-10-26 08:30
Sedana Medical's Nomination Committee for the 2022 Annual General Meeting consists of: Karl Tobieson is appointed chairman of the Nomination Committee. The Nomination Committee represents 26.6 per cent of all voting rights in the company as of September...
2021-10-13 08:30
According to the financial calendar, Sedana Medical plans to publish the report for the third quarter 2021 on Thursday November 4 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the CEO...
2021-09-30 18:30
ESICM Lives 2021 will be held digitally October 3-6 and Sedana Medical will arrange a scientific symposium "Introducing inhaled sedation in intensive care". Every year, the congress attracts over 6,000 physicians and other health care staff...
2021-09-28 08:00
The approval applies to the drug Sedaconda (isoflurane) for administration via the medical device AnaConDa (undergoing name change to Sedaconda ACD) for inhaled sedation in intensive care in Germany. The application has been approved by the German pharmaceutical...
2021-08-30 18:30
ISICEM is the world’s largest conference for intensive care and emergency medicine. Sedana Medical will host a scientific symposium called Introducing inhaled sedation in intensive care. As part of Sedana Medical’s symposium, the national...